Fortress Biotech, Inc. Quarterly Operating Income (Loss) in USD from Q3 2010 to Q3 2024

Taxonomy & unit: us-gaap: USD
Description: The net result for the period of deducting operating expenses from operating revenues.
Summary: Fortress Biotech, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q3 2010 to Q3 2024.
Fortress Biotech, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$22.1M, a 60.6% decline year-over-year.
Fortress Biotech, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$106M, a 40.2% increase year-over-year.
Fortress Biotech, Inc. annual Operating Income (Loss) for 2023 was -$142M, a 30.1% increase from 2022.
Fortress Biotech, Inc. annual Operating Income (Loss) for 2022 was -$204M, a 7.97% decline from 2021.
Fortress Biotech, Inc. annual Operating Income (Loss) for 2021 was -$189M, a 100% decline from 2020.

Operating Income (Loss), Trailing 12 Months (USD)

Operating Income (Loss), Quarterly (USD)

Operating Income (Loss), YoY Quarterly Growth (%)

Period	TTM Value	Value	YoY Chg	Change %	Start Date	End Date	Report	Filed
Q3 2024	-$106M	-$22.1M	-$8.34M	-60.6%	Jul 1, 2024	Sep 30, 2024	10-Q	2024-11-14
Q2 2024	-$97.7M	-$27.8M	+$22.3M	+44.5%	Apr 1, 2024	Jun 30, 2024	10-Q	2024-08-13
Q1 2024	-$120M	-$36.6M	+$22.3M	+37.9%	Jan 1, 2024	Mar 31, 2024	10-Q	2024-05-15
Q4 2023	-$142M	-$19.6M	+$35M	+64.1%	Oct 1, 2023	Dec 31, 2023	10-K	2024-03-28
Q3 2023	-$177M	-$13.8M	+$37M	+72.9%	Jul 1, 2023	Sep 30, 2023	10-Q	2024-11-14
Q2 2023	-$214M	-$50.1M	+$821K	+1.61%	Apr 1, 2023	Jun 30, 2023	10-Q	2024-08-13
Q1 2023	-$215M	-$58.9M	-$11.6M	-24.5%	Jan 1, 2023	Mar 31, 2023	10-Q	2024-05-15
Q4 2022	-$204M	-$54.6M	+$11.1M	+16.9%	Oct 1, 2022	Dec 31, 2022	10-K	2024-03-28
Q3 2022	-$215M	-$50.7M	-$811K	-1.63%	Jul 1, 2022	Sep 30, 2022	10-Q	2023-11-14
Q2 2022	-$214M	-$50.9M	-$8.07M	-18.8%	Apr 1, 2022	Jun 30, 2022	10-Q	2023-08-14
Q1 2022	-$206M	-$47.3M	-$17.3M	-57.5%	Jan 1, 2022	Mar 31, 2022	10-Q	2023-05-15
Q4 2021	-$189M	-$65.7M	-$41.4M	-171%	Oct 1, 2021	Dec 31, 2021	10-K	2023-03-31
Q3 2021	-$147M	-$49.9M	-$26.9M	-117%	Jul 1, 2021	Sep 30, 2021	10-Q	2022-11-14
Q2 2021	-$120M	-$42.9M	-$17.5M	-68.8%	Apr 1, 2021	Jun 30, 2021	10-Q	2022-08-11
Q1 2021	-$103M	-$30M	-$8.49M	-39.4%	Jan 1, 2021	Mar 31, 2021	10-Q	2022-05-12
Q4 2020	-$94.3M	-$24.3M	+$6.08M	+20%	Oct 1, 2020	Dec 31, 2020	10-K	2022-03-28
Q3 2020	-$100M	-$23M	-$503K	-2.23%	Jul 1, 2020	Sep 30, 2020	10-Q	2021-11-15
Q2 2020	-$99.8M	-$25.4M	-$106K	-0.42%	Apr 1, 2020	Jun 30, 2020	10-Q	2021-08-16
Q1 2020	-$99.7M	-$21.5M	+$11.1M	+34%	Jan 1, 2020	Mar 31, 2020	10-Q	2021-05-17
Q4 2019	-$111M	-$30.4M	+$10.8M	+26.3%	Oct 1, 2019	Dec 31, 2019	10-K/A	2021-04-09
Q3 2019	-$122M	-$22.5M	+$5.67M	+20.1%	Jul 1, 2019	Sep 30, 2019	10-Q	2020-11-09
Q2 2019	-$127M	-$25.3M	+$108K	+0.43%	Apr 1, 2019	Jun 30, 2019	10-Q	2020-08-10
Q1 2019	-$127M	-$32.6M	+$1.56M	+4.58%	Jan 1, 2019	Mar 31, 2019	10-Q	2020-05-11
Q4 2018	-$129M	-$41.2M	-$10.6M	-34.6%	Oct 1, 2018	Dec 31, 2018	10-K	2019-03-18
Q3 2018	-$118M	-$28.2M	+$3.59M	+11.3%	Jul 1, 2018	Sep 30, 2018	10-Q	2019-11-12
Q2 2018	-$122M	-$25.4M	+$97K	+0.38%	Apr 1, 2018	Jun 30, 2018	10-Q	2019-08-09
Q1 2018	-$122M	-$34.2M	-$15M	-78.7%	Jan 1, 2018	Mar 31, 2018	10-Q	2019-05-10
Q4 2017	-$107M	-$30.6M	+$1.6M	+4.95%	Oct 1, 2017	Dec 31, 2017	10-K	2019-03-18
Q3 2017	-$109M	-$31.8M	-$14.6M	-85.1%	Jul 1, 2017	Sep 30, 2017	10-K	2019-03-18
Q2 2017	-$94M	-$25.5M	-$8.45M	-49.6%	Apr 1, 2017	Jun 30, 2017	10-K	2019-03-18
Q1 2017	-$85.6M	-$19.1M	-$3.55M	-22.8%	Jan 1, 2017	Mar 31, 2017	10-K	2019-03-18
Q4 2016	-$82M	-$32.2M	-$19.3M	-149%	Oct 1, 2016	Dec 31, 2016	10-K	2018-03-16
Q3 2016	-$62.8M	-$17.2M	+$917K	+5.07%	Jul 1, 2016	Sep 30, 2016	10-K	2018-03-16
Q2 2016	-$63.7M	-$17M	-$9.28M	-120%	Apr 1, 2016	Jun 30, 2016	10-K	2018-03-16
Q1 2016	-$54.4M	-$15.6M	-$3M	-23.9%	Jan 1, 2016	Mar 31, 2016	10-K	2018-03-16
Q4 2015	-$51.4M	-$13M	-$8M	-161%	Oct 1, 2015	Dec 31, 2015	10-K	2017-03-16
Q3 2015	-$43.4M	-$18.1M	-$13.8M	-316%	Jul 1, 2015	Sep 30, 2015	10-K	2017-03-16
Q2 2015	-$29.6M	-$7.76M	-$3M	-63%	Apr 1, 2015	Jun 30, 2015	10-K	2017-03-16
Q1 2015	-$26.6M	-$12.6M	-$5.99M	-91%	Jan 1, 2015	Mar 31, 2015	10-K	2017-03-16
Q4 2014	-$20.7M	-$4.96M	+$4.56M	+47.9%	Oct 1, 2014	Dec 31, 2014	10-K	2016-03-15
Q3 2014	-$25.2M	-$4.35M	+$3.16M	+42.1%	Jul 1, 2014	Sep 30, 2014	10-K	2016-03-15
Q2 2014	-$28.4M	-$4.76M	+$5.53M	+53.7%	Apr 1, 2014	Jun 30, 2014	10-K	2016-03-15
Q1 2014	-$33.9M	-$6.58M	+$1.88M	+22.2%	Jan 1, 2014	Mar 31, 2014	10-K	2016-03-15
Q4 2013	-$35.8M	-$9.52M	-$1.23M	-14.8%	Oct 1, 2013	Dec 31, 2013	10-K	2015-03-16
Q3 2013	-$34.6M	-$7.5M	-$1.67M	-28.7%	Jul 1, 2013	Sep 30, 2013	10-K	2015-03-16
Q2 2013	-$32.9M	-$10.3M	-$3.83M	-59.2%	Apr 1, 2013	Jun 30, 2013	10-K	2015-03-16
Q1 2013	-$29.1M	-$8.46M	-$1.88M	-28.5%	Jan 1, 2013	Mar 31, 2013	10-K	2015-03-16
Q4 2012	-$27.2M	-$8.3M	-$3.07M	-58.6%	Oct 1, 2012	Dec 31, 2012	10-K	2014-03-14
Q3 2012	-$24.1M	-$5.83M	-$2.3M	-65.1%	Jul 1, 2012	Sep 30, 2012	10-K	2014-03-14
Q2 2012	-$21.8M	-$6.47M	-$2.73M	-73%	Apr 1, 2012	Jun 30, 2012	10-K	2014-03-14
Q1 2012	-$19.1M	-$6.58M	+$16M	+70.8%	Jan 1, 2012	Mar 31, 2012	10-K	2014-03-14
Q4 2011	-$35M	-$5.23M			Oct 1, 2011	Dec 31, 2011	10-K	2013-03-18
Q3 2011		-$3.53M	-$1.45M	-69.6%	Jul 1, 2011	Sep 30, 2011	10-K	2013-03-18
Q2 2011		-$3.74M			Apr 1, 2011	Jun 30, 2011	10-K	2013-03-18
Q1 2011		-$22.5M			Jan 1, 2011	Mar 31, 2011	10-K	2013-03-18
Q3 2010		-$2.08M			Jul 1, 2010	Sep 30, 2010	10-Q	2011-11-14

* An asterisk sign (*) next to the value indicates that the value is likely invalid.